Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03418753 · ClinicalTrials.gov registry record
Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure
A clinical trial, sponsored by Oculogica.
- Completed
- Registry status
- 60
- Enrollment target
NCT03418753 is a clinical trial that has completed, run by Oculogica. The registered enrollment target is 60 participants.
The verdict
NCT03418753 has completed, sponsored by Oculogica.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
The study is a prospective, multi-center, non-randomized, open label observational study. The objective of this study is to compare the accuracy of the EyeBOX to a clinical diagnosis of abnormal ICP as determined by an external ventriculostomy drain (EVD) or ventriculostomy catheter.
Interventions
- DIAGNOSTIC_TEST EyeBOX for ICP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-05-10 |
| Est. Completion | 2023-05-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03418753
The ClinicalTrials.gov registry entry for NCT03418753 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oculogica, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EyeBOX for ICP is the first listed.
NCT03418753 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03418753 about?
NCT03418753 is a clinical study titled "Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure". The study is a prospective, multi-center, non-randomized, open label observational study. The objective of this study is to compare the accuracy of the EyeBOX to a clinical diagnosis of abnormal ICP as determined by an external ventriculostomy drain (EVD) or ventriculostomy catheter.
What is the current status of trial NCT03418753?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2018-05-10. Estimated completion is 2023-05-10.
What interventions are being tested in trial NCT03418753?
The interventions under investigation include: EyeBOX for ICP (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03418753?
This trial is sponsored by Oculogica, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.